DBP-1400-ABE and DBP-2003- ABE
Aed Battery Exchange, LLC · Decision date Oct 28, 2025
What did the FDA approve?
FDA records P190013/S001 as a supplement to PMA P190013, with the supplement type “Normal 180 Day Track”. The recorded decision is approval, dated Oct 28, 2025.
FDA approval order statement
approval for two new models of re-celled automated external defibrillator (AED) batteries, models DBP-1400-ABE and DBP-2003-ABE.
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 28, 2025
- FDA change category
- Change Design/Components/Specifications/Material
Regulatory record facts
- Identifier
- P190013/S001
- Regulatory pathway
- PMA supplement
- Applicant
- Aed Battery Exchange, LLC
- Product code
- MKJ
- Decision code
- APPR
- Decision date
- Oct 28, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Automated external defibrillators (non-wearable).
- Applicant
- Aed Battery Exchange, LLC
- Product code
- MKJ
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P190013/S001 received
Application receipt date recorded by FDA.
P190013/S001 · FDA decision
Normal 180 Day Track
Timeline entries are records held by MedtechLedger for P190013. View FDA’s full supplement list.
Related devices and submissions
Explore the linked device profile
Other records with product code MKJ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
LIFEPAK 35 monitor/defibrillatorP160026/S076 | Physio-Control, Inc. | PMA supplement | Oct 29, 2026 | FDA |
AED 3 Defibrillator with Uni-PadzP160015/S029 | ZOLL MEDICAL CORPORATION | PMA supplement | Oct 16, 2026 | FDA |
ZOLL R Series Monitor/DefibrillatorP160022/S056 | ZOLL MEDICAL CORPORATION | PMA supplement | Oct 16, 2026 | FDA |
| ZOLL MEDICAL CORPORATION | PMA supplement | Oct 2, 2026 | FDA | |
| Physio-Control, Inc. | PMA supplement | Sep 24, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Aed Battery Exchange, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 1000 Brown St., Suite #206, Wauconda, IL, 60084
Sources and methodology
- Original FDA record: P190013/S001
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

